Articles | Volume 4, issue 5
https://doi.org/10.7150/jbji.37980
https://doi.org/10.7150/jbji.37980
Case report
 | 
15 Oct 2019
Case report |  | 15 Oct 2019

Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis

Tariq Azamgarhi, James Donaldson, Ashik Shah, and Simon Warren

Keywords: Periprosthetic joint infection, Lipoglycopeptide, Coagulase negative staphylococcus epidermidis, Osteomyelitis

Abstract. We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.